Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer to Supply Neonatal Screening Tech to Russian Health Ministry

NEW YORK, May 2 (GenomeWeb News) - PerkinElmer said yesterday that it has signed a multi-year agreement with the Russian Ministry of Health to supply neonatal screening technology in the country.


PerkinElmer said the agreement follows a recent decision by the Russian Ministry to expand to five from two the number of standard tests in its national screening program, which will now also include screening tests for cystic fibrosis, adrenal hyperplasia, and galactosemia.


Under the terms of the agreement, PerkinElmer will provide multiple Russian laboratories with its DELFIA screening platform, including reagents, software, and instrumentation for screening those disorders, as well as for the existing tests for hypothyroidism and phenylketonuria.


Financial details were not disclosed.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.